Brief: Hamlet Pharma Gets Patent In Europe
25/11/2020 08:34
Nov 25 (Reuters) - Hamlet Pharma AB HAMLET.TE :
* ALPHA1H PATENT GRANTED IN EUROPE
* PROTECTION IS GRANTED AS EUROPEAN PATENT NUMBER EP 3618848
B1,
WHICH WILL REMAIN VALID UNTIL MAY 14, 2038.
Source text for Eikon: ID:nWkr7z8pV6
Further company coverage: HAMLET.TE
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))